Literature DB >> 25194295

Adverse left ventricular remodeling in community-dwelling older adults predicts incident heart failure and mortality.

Michael R Zile1, William H Gaasch2, Kanan Patel3, Inmaculada B Aban3, Ali Ahmed4.   

Abstract

OBJECTIVES: This study sought to determine whether specific patterns of adverse left ventricular (LV) structural remodeling are associated with differential rates of cardiovascular (CV) outcomes.
BACKGROUND: It is not known whether a stepwise combinatorial assessment of LV volume, mass, and geometry done to define specific remodeling patterns provides incremental prognostic information.
METHODS: A total of 3,181 Cardiovascular Health Study participants (mean age, 73 years of age; 60% women, 5% African American) were categorized by LV remodeling patterns and related to a multivariate-adjusted (age, sex, race, ejection fraction, hypertension, myocardial infarction, diabetes mellitus, chronic kidney disease) analysis of CV outcomes (incident heart failure [HF], all-cause mortality, and a combined endpoint of HF and mortality) over a 13-year follow-up period.
RESULTS: Examined independently, either left ventricular enlargement (LVE) or left ventricular hypertrophy (LVH) was associated with a higher risk of HF (32%, 34%, respectively) than with normal geometry (17%; p < 0.001). When LV volume and mass were used in combination, important incremental prognostic information was achieved. In the absence of LVE, HF was more common in those with LVH than in those with normal mass (32% vs. 16%, respectively; p < 0.001). In the presence of LVE, HF was more common in those with LVH than in those with normal mass (37% vs. 29%, respectively; p = 0.021). The subgroup with normal volume and mass but relative wall thickness (RWT) >0.42 carried a higher risk of HF (21%) than those with normal geometry (15%; p = 0.011). Once LVH or LVE was present, the addition of RWT to this analysis did not affect HF rate. Similar results were obtained for the other CV outcomes.
CONCLUSIONS: Stepwise combinatorial assessment of LV volume, mass, and geometry provides incremental prognostic information regarding CV outcomes.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  heart failure; left ventricle; structural remodeling

Mesh:

Year:  2014        PMID: 25194295     DOI: 10.1016/j.jchf.2014.03.016

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  34 in total

1.  Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study.

Authors:  Gabriela Querejeta Roca; Susan Redline; Brian Claggett; Natalie Bello; Christie M Ballantyne; Scott D Solomon; Amil M Shah
Journal:  Circulation       Date:  2015-08-27       Impact factor: 29.690

2.  Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.

Authors:  Leila R Zelnick; Ronit Katz; Bessie A Young; Adolfo Correa; Bryan R Kestenbaum; Ian H de Boer; Nisha Bansal
Journal:  Am J Kidney Dis       Date:  2017-01-28       Impact factor: 8.860

3.  Deficiency of bone morphogenetic protein-3b induces metabolic syndrome and increases adipogenesis.

Authors:  Íngrid Martí-Pàmies; Robrecht Thoonen; Patrick Seale; Alexia Vite; Alex Caplan; Jesus Tamez; Lauren Graves; Wei Han; Emmanuel S Buys; Donald B Bloch; Marielle Scherrer-Crosbie
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-06-30       Impact factor: 4.310

4.  Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study.

Authors:  Ambarish Pandey; Neil Keshvani; Colby Ayers; Adolfo Correa; Mark H Drazner; Alana Lewis; Carlos J Rodriguez; Michael E Hall; Ervin R Fox; Robert J Mentz; Christopher deFilippi; Stephen L Seliger; Christie M Ballantyne; Ian J Neeland; James A de Lemos; Jarett D Berry
Journal:  JAMA Cardiol       Date:  2019-01-01       Impact factor: 14.676

Review 5.  Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs.

Authors:  Tiago Fernandes; Valério G Baraúna; Carlos E Negrão; M Ian Phillips; Edilamar M Oliveira
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

6.  Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population.

Authors:  Sonia Garg; James A de Lemos; Colby Ayers; Michel G Khouri; Ambarish Pandey; Jarett D Berry; Ronald M Peshock; Mark H Drazner
Journal:  JACC Cardiovasc Imaging       Date:  2015-08-19

7.  Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.

Authors:  Michael R Zile; Vinod Sharma; James W Johnson; Eduardo N Warman; Catalin F Baicu; Tom D Bennett
Journal:  Circ Heart Fail       Date:  2015-12-23       Impact factor: 8.790

8.  Identification of High-Risk Left Ventricular Hypertrophy on Calcium Scoring Cardiac Computed Tomography Scans: Validation in the DHS.

Authors:  Fernando U Kay; Suhny Abbara; Parag H Joshi; Sonia Garg; Amit Khera; Ronald M Peshock
Journal:  Circ Cardiovasc Imaging       Date:  2020-02-18       Impact factor: 7.792

9.  Smoking and Cardiac Structure and Function in the Elderly: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  Wilson Nadruz; Brian Claggett; Alexandra Gonçalves; Gabriela Querejeta-Roca; Miguel M Fernandes-Silva; Amil M Shah; Susan Cheng; Hirofumi Tanaka; Gerardo Heiss; Dalane W Kitzman; Scott D Solomon
Journal:  Circ Cardiovasc Imaging       Date:  2016-09       Impact factor: 7.792

10.  The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice.

Authors:  Peiheng Gan; Catalin Baicu; Hirofumi Watanabe; Kristy Wang; Ge Tao; Daniel P Judge; Michael R Zile; Takako Makita; Rupak Mukherjee; Henry M Sucov
Journal:  Hum Mol Genet       Date:  2021-01-06       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.